Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.6574 USD | +1.12% | -1.15% | -13.77% |
May. 07 | Traws Pharma Completes First Cohort Dosed in Phase 1 Trial for COVID Therapy | CI |
Apr. 04 | North American Morning Briefing : Focus Turns to -2- | DJ |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-13.77% | 13.71M | |
+29.73% | 49.18B | |
+0.91% | 42.11B | |
+50.47% | 40.37B | |
-5.26% | 28.85B | |
+13.70% | 26.09B | |
-23.02% | 18.71B | |
+8.29% | 13.26B | |
+32.60% | 12.32B | |
-1.30% | 11.99B |
- Stock Market
- Equities
- TRAW Stock
- News Traws Pharma, Inc.
- Transcript : Onconova Therapeutics, Inc., Q3 2022 Earnings Call, Nov 14, 2022